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Abstract
Background: Cellular interactions between thymocytes and thymic stromal cells are critical for normal T cell development.
Thymic epithelial cells (TECs) are important stromal niche cells that provide essential growth factors, cytokines, and present
self-antigens to developing thymocytes. The identification of genes that mediate cellular crosstalk in the thymus is ongoing.
One candidate gene, Adam17, encodes a metalloprotease that functions by cleaving the ectodomain of several
transmembrane proteins and regulates various developmental processes. In conventional Adam17 knockout mice, a non-
cell autonomous role for ADAM17 in adult T cell development was reported, which strongly suggested that expression of
ADAM17 in TECs was required for normal T cell development. However, knockdown of Adam17 results in multisystem
developmental defects and perinatal lethality, which has made study of the role of Adam17 in specific cell types difficult.
Here, we examined T cell and thymic epithelial cell development using a conditional knockout approach.
Methodology/Principal Findings: We generated an Adam17 conditional knockout mouse in which floxed Adam17 is
deleted specifically in TECs by Cre recombinase under the control of the Foxn1 promoter. Normal T cell lineage choice and
development through the canonical ab T cell stages was observed. Interestingly, Adam17 deficiency in TECs resulted in
reduced expression of the transcription factor Aire. However, no alterations in the patterns of TEC phenotypic marker
expression and thymus morphology were noted.
Conclusions/Significance: In contrast to expectation, our data clearly shows that absence of Adam17 in TECs is dispensable
for normal T cell development. Differentiation of TECs is also unaffected by loss of Adam17 based on phenotypic markers.
Surprisingly, we have uncovered a novel genetic link between Adam17and Aire expression in vivo. The cell type in which
ADAM17 mediates its non-cell autonomous impact and the mechanisms by which it regulates intrathymic T cell
development remain to be identified.
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Introduction
Proper intercellular communication is critical for the development
of T cells in the thymus. Hematopoietic progenitors must receive
signals from the thymic microenvironment to proliferate, differenti-
ate, and undergo positive and negative selection [1]. Thymocyte
progenitorsenterthethymusatthecorticomedullaryjunctionandare
identified as CD4
2 CD8
2 ‘‘double negative’’ (DN) stage. During the
generation of TCRab
+ T cells, they then progress through four DN
stages characterized by the expression of CD44 and CD25 (DN1:
CD44
+CD25
2,D N 2 :C D 4 4
+CD25
+,D N 3 :C D 4 4
2CD25
+,a n d
DN4: CD44
2CD25
2)[ 2 ] .A f t e rT C R b selection in the DN3 stage
thymocytes progress through the transitory DN4 stage to the CD4
+
CD8
+ ‘‘double positive’’ (DP) stage, and then undergo both positive
and negative selection prior to being released as single positive (SP)
CD4 or CD8 T cells. The thymocytes migrate through anatomically
distinct thymic microenvironments as they progress through these
developmental stages (reviewed in [1]).
The identification of genes that mediate cellular crosstalk in the
thymus during T cell development is an area of active investigation
[3]. Adam17 (Entrez GeneID: 11491; also known as TNFa-
converting enzyme (TACE)), for example, has been proposed as
one of these genes. The metalloprotease ADAM17 has a well
characterized ‘‘sheddase’’ activity, in which it releases membrane
bound proteins from the cell surface, often initiating their signaling
ability [4,5,6,7]. ADAM17 can also participate in the process of
regulated intramembrane proteolysis in which it cleaves the
extracellular portion of a transmembrane receptor, which leads to
intracellular cleavage by the c-secretase complex and resultant
cellular signaling [8]. By analyzing the temporal and spatial
activities of ADAM17, we can gain insights into the regulation of
cellular signaling in the thymus.
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logically relevant substrates (reviewed in [9]). It was initially
described for its role in shedding the transmembrane precursor of
soluble TNFa [4,10]. Subsequently, it was described to regulate
cell surface expression of TNFR-I [11], TNFR-II [12], Notch
[13], Delta-like-1 [14], SCF [15], CD40 [16], L-selectin [17],
CX3CL1 [18], LAG3 [19], Flt3L [20] and several other
transmembrane proteins that are relevant to immune system
development. Through a conventional knockout (KO) approach,
it became clear that ADAM17 is critically important for the
development of epithelial tissues via its regulation of the EGFR
signaling pathway [17]. ADAM17 acts to shed EGF family
ligands, a mechanism that is implicated in the development of
mammary epithelium, heart valves, skin, and hair [17,21,22].
However, due to perinatal lethality of Adam17
DZn/DZn conven-
tional knockout mice (in which mutated ADAM17 that lacks its
critical zinc binding ability is expressed), analyses of adult
physiology could not be assessed. Conditional knockout of Adam17
using the Cre/Lox system has recently solved this issue and
revealed Adam17’s importance in inflammation [23].
The role of ADAM17 in adult T cell development is largely
unknown at a mechanistic level. The current literature describes a
block from the DN to DP stage of thymopoiesis in Adam17
DZn/DZn
mice that survive to adulthood on a mixed B6 and 129S3
background [24,25]. Importantly, through transplantation of
Adam17
DZn/DZn bone marrow into RAG
2/2 recipient mice, this
block was shown to be non-cell autonomous to the hematopoietic
compartment [25]. This line of experimentation indicated that
the likely location of ADAM17’s role in T cell development as the
thymic stroma. Through in vitro assays analyzing the effect of
the cleavage of the Notch ligand Dll1, our laboratory determin-
ed that modulation of the Notch signaling pathway is not likely
the causative mechanism of the defect in Adam17
DZn/DZn mice
[26].
Thymic epithelial cells (TECs) are thought to be a principal
component of the thymic stroma that provides signals to
developing thymocytes, and we therefore hypothesized that
ADAM17 in TECs plays a key non-cell autonomous role on
development of T cells. In order to assess the role of ADAM17
specifically in adult TECs, we devised a conditional knockout
strategy in which Adam17 ‘‘floxed’’ mice [23] were crossed with
Foxn1-Cre mice [27]. In these ADAM17 conditional knockout
mice (Adam17/Foxn1), Adam17 was effectively deleted from
TECs. Surprisingly, T cell development was unaffected in
Adam17/Foxn1 mice. Interestingly, analysis of TECs revealed an
unaltered TEC population structure, but a strong reduction of
Aire mRNA expression. The lack of T cell phenotype in these
mice requires a re-assessment of the proposed role of ADAM17
in the thymus.
Results
Generation of TEC-specific Adam17 knockout mice
Mice expressing Cre under the control of the Foxn1 promoter
[27] were crossed with Adam17 exon2-floxed mice [23].
Specificity of Cre expression in TECs has previously been
demonstrated and its utility in in vivo functional assays has been
validated [28]. To further confirm Cre restriction to the TEC
compartment, we performed TEC digestions from 1 week old
Foxn1-Cre mice. CD45
2 and CD45
+ fractions were separated by
MACS and the CD8
+ fraction of thymocytes was further purified
by FACS. RT-PCR for Cre expression revealed high levels of Cre
in the CD45
2 fraction enriched for TECs, but low to no
expression in other sorted populations (Figure 1A). Mice of the
genotype Foxn1-Cre/Adam17
flox/flox (referred to as Adam17/Foxn1)
were present in expected Mendelian ratios compared to
littermate controls and had no overt phenotypes or distinctive
external features (data not shown), unlike Adam17
DZn/DZn mice
[17].
To confirm knockdown of gene expression, Adam17 levels were
assessed by qRT-PCR. TECs were digested, MACS enriched for
CD45
2 cells, and further sorted by FACS based on EpCAM
expression. Quantitative Adam17 levels were determined using
primers specific to the floxed region of Adam17. EpCAM
+ TECs
from Adam17/Foxn1 mice displayed less than 2% the Adam17 levels
of littermate controls (Figure 1B). Furthermore, RT-PCR
confirmed the presence of the truncated, null form of the mRNA
transcript expected after recombination in Adam17/Foxn1 mice,
while the wildtype form of the transcript was present in both
Adam17
flox/+ and Foxn1-Cre/Adam17
flox/+ mice (Figure 1C).
Figure 1. ADAM17 is efficiently deleted in TECs from Adam17/Foxn1 mice. (A) MACS-sorted CD45
+ and CD45
- fractions, and FACS-sorted
CD8
+ cells of 13 pooled thymi from 1-week old Foxn1-Cre mice were assessed for the expression of Cre recombinase using b-actin as a loading
control. MACS-sorted CD45
+ cells from B6 thymus were used as a negative control. (B) CD45
-Ter119
-EpCAM
+ TECs from 8-week old Control (fl/+ or fl/fl)
or Adam17/Foxn1 (Cre fl/fl) mice were assessed for Adam17 levels by quantitative RT-PCR. Each data point represents a pool of at least 3 thymi of the
indicated genotype from 3 independent experiments. Adam17 expression levels were determined relative to control mice, using Gapdh expression as
the internal control The mean Adam17 expression is shown (**p,0.01, Student’s t-test). (C) RT-PCR analysis for the exon2-deleted null transcript
(180bp amplicon) or the wildtype transcript (313bp amplicon) in CD45
-Ter119
-EpCAM
+ FACS sorted TECs from 8-week old mice. Mice were pooled to
obtain ample genetic material for RT-PCR: fl/+,n=6 ;Cre fl/+,n=4 ;Cre fl/fl,n=6 .
doi:10.1371/journal.pone.0013528.g001
TEC-Specific ADAM17 Knockout
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mice
Conventional Adam17 KO mice exhibit a non-cell autonomous
block in T cell development from the DN to DP stage, which
indicated a likely role for ADAM17 on TECs [25]. However, in
our TEC-specific Adam17/Foxn1 knockout mice, the thymus and
spleen are of normal size (Figure 2A). Likewise, analysis of
intrathymic populations revealed indistinguishable numbers of
DN, DP, CD4SP, and CD8SP thymocytes between control and
Adam17/Foxn1 mice (Figure 2B). Furthermore, the frequencies and
absolute numbers of DN1 through DN4 stages of thymocyte
development were unaltered in the absence of ADAM17 on TECs
(Figure 2C, and data not shown). Likewise, analysis of regulatory T
cells showed no alterations in the frequency of CD4SP thymocytes
expressing FoxP3 or CD25 nor CD4SP splenocytes expressing
FoxP3 (Figure S1). These results are not consistent with the
hypothesis that the ADAM17 non-cell autonomous role in T cell
development is localized to the TECs.
Aire expression is diminished in Adam17/Foxn1 TECs
We next examined whether deletion of ADAM17 in TECs
affected their development and expression of TEC-specific genes
in a cell-autonomous fashion. Analysis of gene expression in
FACS-sorted EPCAM
+ TECs by qRT-PCR yielded the unex-
pected finding that the autoimmune regulator transcription factor,
Aire, was diminished in Adam17/Foxn1 mice (Figure 3A). Aire
mutations have been implicated in the human disease APECED,
which may result from defective medullary TEC development,
and/or lack of expression of tissue-specific antigens (TRAs) that
result in alterations in negative selection of thymocytes (reviewed
in [29]). Aire mRNA expression in TECs in Adam17/Foxn1 mice
was less than 10% of control mice. TRAs whose expression is
dependent or independent of Aire have been previously described
[30]. The Aire-dependent TRA, Casein a (Csna), was significantly
reduced in Adam17/Foxn1 mice relative to controls (Figure 3B).
However, other Aire-dependent TRAs, Casein c (Csnc), Salivary
protein 1 (Spt1), and Insulin 2 (Ins2), were not reduced. As expected,
Aire-independent TRAs, Casein b (Csnb), Casein k (Csnk), and
Glutamic acid decarboxylase-67 (Gad67), were expressed similarly
between Adam17/Foxn1 and control mice (Figure 3B).
To assess why there was not a more pronounced reduction in
Aire-dependent TRAs in Adam17/Foxn1 thymi, we analyzed Aire
protein levels by immunohistochemistry and flow cytometry. Aire
protein was clearly present in Adam17/Foxn1 thymi based on
immunofluorescence analysis of thymic tissue sections (Figure 4A).
Furthermore, thymi were properly organized into outer cortical
and inner medullary regions as assessed by staining with the
predominantly medullary marker Keratin-5 and the predomi-
nantly cortical marker Keratin-8 (Figure 4A) [31]. Morphome-
trical analyses of the thymic sections did not did not reveal any
quantitative differences in the size of the medullary regions or the
numbers of Aire
+ cells in the medulla between controls and
Adam17/Foxn1 thymi (data not shown). Flow cytometric analysis of
TECs, to measure the percentage of Aire
+ events within the
EpCAM
+ fraction, indicated a reduction in the frequency of TECs
that express Aire in Adam17/Foxn1 thymi (Figure 4B). From two
independent experiments, the frequency of Aire
+ TECs in
Adam17/Foxn1 thymi was 65% and 85% of control mice
(Figure 4B and data not shown). Furthermore, the mean
fluorescence intensity of the events in the EpCAM
+Aire
+ gate
was reduced to 92% and 96% of control levels in two independent
experiments (Figure 4B and data not shown). The more modest
reduction in Aire protein levels relative to the more pronounced
reduction in mRNA levels may explain why Aire-dependent TRAs
are not more significantly altered in Adam17/Foxn1 thymi. To
confirm the identity of Aire
+ TECs, we stained for CD80 and
Figure 2. T cell developmental progression and thymocyte cellularity are unaltered in Adam17/Foxn1 mice. (A) Representative image
of the thymus and spleen extracted from 4-week old Control or Adam17/Foxn1 mice. (B) Total cell numbers from individual mice of the indicated
genotype. Data represent mean + SD; Control,n=6 ;Adam17/Foxn1,n=8 .p .0.05 for all comparisons between Control and Adam17/Foxn1 thymocyte
populations. (C) Representative flow cytometry data from Control and Adam17/Foxn1 mice showing CD4 versus CD8 profiles and DN1 through DN4
stages, as assessed by CD44 and CD25 staining within the DN gate. Control: fl/+ or fl/fl; Adam17/Foxn1: Cre fl/fl.
doi:10.1371/journal.pone.0013528.g002
TEC-Specific ADAM17 Knockout
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+ cells in both control and Adam17/Foxn1
mice expressed CD80 (Figure 4C), consistent with the previous
literature [32].
Thymic stromal populations are unaltered in Adam17/
Foxn1 mice
In order to determine if the observed reduction in Aire levels were
the result of a reduction in mature medullary TECs (mTECs) or an
alteration in another thymic population, we stained for markers of
thymic stromal cells. Critically, EpCAM
+ TECs were unaltered both
in number and frequency in Adam17/Foxn1 mice (Figure 5A, D, E).
mTECs at the terminal stage of differentiation upregulate Aire
expression and can be identified by several surface markers [33]. To
address whether lack of ADAM17 results in a loss of mature Aire
+
mTECs, we stained with the mTEC markers UEA1, CD80, and
MHCII [34]. TEC subpopulation analysis revealed similar percent-
ages of medullary TECs, as shown by the marker UEA1 (Figure 5B,
F), and normal proportions of mature and immature medullary TEC
subsets as assessed by high and intermediate MHCII levels,
respectively (Figure 5C). Also, Aire
+ TECs in both control and
Adam17/Foxn1thymialso highly expressed CD80, corresponding to a
mature medullary TEC phenotype, while Aire
2 TECs were
predominantly CD80
low (Figure 4C). These combined data indicate
that, based on phenotypic TEC markers and histological examina-
tion, the medullary compartment in Adam17/Foxn1 mice is normal
despite the clear reduction in Aire mRNA expression. Furthermore,
staining with the antibody MTS15 [35] revealed normal proportions
of MTS15
+ thymic fibroblasts in Adam17/Foxn1 mice (Figure 5A,G).
ADAM17 and EGF substrates are expressed on non-TEC
thymic stroma
Since Adam17/Foxn1 thymi do not display the T cell develop-
mental block observed in Adam17 conventional knockout mice [25],
it is possible that ADAM17 in another thymic stromal cell type is
used during T cell development. To assess this possibility, we
examined the non-TEC stroma for presence of ADAM17 and EGF
family ligands, which have been shown to be key substrates for
ADAM17 in vivo. First, to confirm ADAM17 expression on non-
TEC stroma, we FACS sorted CD45
2Ter119
2EpCAM
2 cells
from normal B6 mice. Quantitative PCR revealed levels of Adam17
expression in these non-TECs, at least as high as that of TECs
(Figure 6A). We then proceeded to examine more specific stromal
cell populations, including CD45
2Ter119
2EpCAM
2MTS15
+
thymic fibroblasts and the CD45
2Ter119
2EpCAM
2MTS15
2
populations containing thymic endothelial cells and other mesen-
chyme [35] (Figure 5A). Notably, in thymic fibroblasts, we observed
levels of TGFa and HB-EGF that were elevated relative to those of
TECs, as well as the presence of the EGF receptor (Figure 6B). This
indicates that ADAM17 and EGF pathway substrates shown to be
critical in other developmental systems are present on the non-TEC
populations in the thymus.
Adam10 expression is not altered on Adam17/Foxn1
thymic stroma
ADAM10 has a high degree of substrate overlap with ADAM17
and may function to compensate for ADAM17 deficiency in vivo.
ADAM10 has been shown to be tightly regulated at the
transcriptional level, whereas ADAM17 is predominantly activat-
ed in a post-transcriptional manner [6,19]. To assess whether
Adam10 expression is altered in the thymus following deletion of
Adam17, we performed qRT-PCR on sorted EpCAM
+ TECs and
EpCAM
2 stroma. We did not see any alteration in Adam10 levels
in TECs or non-TEC stroma in Adam17/Foxn1 mice (Figure S2).
Discussion
Loss of Adam17 results in a profound non-cell autonomous T cell
developmental block in conventional knockout mice, and the
underlying assumption from the previous literature was that
Figure 3. Aire mRNA expression is reduced in Adam17/Foxn1 EpCAM
+ TECs. FACS-sorted CD45
-Ter119
-EpCAM
+ TECs were pooled from 8-
week old Control and Adam17/Foxn1 mice (n$3 for each pool). qRT-PCR for Aire (A) and TRA (B) expression was determined from 3 independent
experiments. Rpl7 was used as the internal control and expression levels were determined relative to mean expression in Control mice. Data represent
mean + SD; p,0.05 (*), p,0.01 (**), p,0.001 (***). Control: fl/+ or fl/fl; Adam17/Foxn1: Cre fl/fl.
doi:10.1371/journal.pone.0013528.g003
TEC-Specific ADAM17 Knockout
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this block [25]. In the present study, we have conditionally
knocked out Adam17 in thymic epithelial cells expressing the
transcription factor Foxn1 [27]. We have convincingly shown that
wildtype Adam17 is eliminated at the mRNA level by both
quantitative and standard RT-PCR strategies. Surprisingly,
Adam17/Foxn1 conditional KO mice do not possess a similar
block in T cell development to Adam17 conventional knockout
mice. No hematopoietic lineage was statistically different in
percentage or total cell numbers in the Adam17/Foxn1 thymus
compared to controls. We have also performed a limited analysis
of embryonic day 17.5 thymi in conventional Adam17 knockout
mice, and have not observed any differences in thymocyte subset
or TEC subset frequencies at this earlier developmental stage
(Gravano et al., unpublished observations). Therefore, we
conclude that TEC subsets are unaltered at either the fetal or
adult stages in the absence of Adam17. In addition, our results show
that unlike the thymus in the postnatal conventional Adam17
knockout mice [25], the thymus in TEC-specific, Adam17 knockout
mice is not defective in the generation of T cells. Our data support
the idea that Adam17 is a regulator of adult, but not fetal, thymic
development, but is not dependent on Aire levels. Our results,
which show that Adam17 in TECs is not necessary for thymic
development, were contrary to expectation, but could be
explained by several possible reasons, described below.
First, ADAM17 may be acting within the thymic microenvi-
ronment to regulate T cell development, but on a non-epithelial
cell type (see conceptual model shown in Figure 7). Consistent with
this idea, we have observed high levels of Adam17 expression on
the CD45
2EpCAM
2 population of cells in the thymus, which
contain fibroblasts, endothelial cells, and other mesenchymal cells.
Furthermore, these non-epithelial cell types are unaffected in
Adam17/Foxn1 mice. In addition, TGFa and HB-EGF, two EGF
pathway ligands shed by ADAM17 during the development of
other epithelial tissues, are expressed at high levels in adult thymic
fibroblasts relative to TECs. It is has been well established that
growth factors such as FGF7 and FGF10 are secreted from the
neural crest-derived mesenchyme that surrounds the thymic
Figure 4. Adam17/Foxn1 mice display normal cortico-medullary thymic architecture. (A) Representative thymic sections from 8-week old
mice stained for Keratin-5 (K8), Keratin-8 (K8), and Aire. Inset displays a higher magnification image demonstrating the typical speckled nuclear Aire
staining [59] that is present in both Control and Adam17/Foxn1 thymi. (B) Thymi from 11-week old mice were pooled and digested and
CD45
-Ter119
-EpCAM
+ TECs were analyzed for Aire expression (n$3 for each pool). Aire
+ gates were determined on the basis of IgG2c isotype control
staining. (C) CD80 levels were determined for Aire
+ and Aire
- TECs based on gating in Part B. MFI, mean fluorescence intensity. Control: fl/+ or fl/fl;
Adam17/Foxn1: Cre fl/fl.
doi:10.1371/journal.pone.0013528.g004
TEC-Specific ADAM17 Knockout
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mesenchyme regulates TEC development, proliferation and ability
to support thymopoiesis. Through fetal thymic organ culture
experiments it has been shown that this mesenchymal support can
be replaced by addition of the soluble ADAM17 substrate TGFa
[37]. Thus, ADAM17 may potentially be produced by non-TEC
stroma during the fetal and/or adult stages to promote the
development and proliferation of TECs, facilitating proper
thymocyte development. Alternatively, signals shed by ADAM17
on non-TEC stroma may target the thymocytes directly. It has
previously been shown that thymic mesenchyme and fibroblasts
can play a direct role in early T cell development [38,39].
Recently, intrathymic PDGFR
+ pericytes of neural crest origin
have been show to promote thymocyte egress, highlighting the
importance of non-TEC stroma in thymus physiology [40,41].
Second, it is possible that there is an extrathymic requirement
for ADAM17 for proper T cell development (Figure 7). Since
ADAM17 sheds factors that can act systemically [17], it is possible
that extrathymically derived factors influence intrathymic devel-
opment. The multiple systemic defects in Adam17
DZn/DZn mice also
support this hypothesis [17]. For example, the DP thymocyte
subset, which is the population reduced in Adam17
DZn/DZn mice
[25], is highly sensitive to levels of systemic factors such as
glucocorticoids, which are involved in metabolism and stress
response [42]. Adult Adam17
DZn/DZn mice have a lean and
hypermetabolic phenotype characterized by reduced fat mass
despite normal food intake. However, corticosterone (the major
glucocorticoid in mice) was not altered in Adam17
DZn/DZn mice
[24]. Interestingly, plasma levels of leptin, a key factor in the
energy homeostasis system, were reduced approximately 2-fold in
Adam17
DZn/DZn mice. Leptin-deficient ob/ob mice possess a high
level of DP thymocyte apoptosis, which can be reversed by
addition of recombinant leptin [43]. Leptin has been shown to act
by protecting thymocytes from glucocorticoid induced apoptosis
[44]. The phenotype of ob/ob DP thymocytes is very similar to
Adam17
DZn/DZn mice. It remains to be determined if changes in
these systemic factors (which would not be deleted in the Adam17/
Foxn1 mice) are the cause of the thymic hypocellularity in
Adam17
DZn/DZn mice.
Our data show that Adam17/Foxn1 mice have reduced
expression of the transcription factor Aire in TECs, but this
reduction does not affect TEC population composition. Mutations
in Aire have been associated with autoimmune disease in humans
and in mouse models [29]. Adam17/Foxn1 mice do not display any
overt phenotypes that would indicate autoimmune disease, which
is consistent with the normal thymic phenotype and production of
mature T cells observed in two-to-three-month-old Aire KO mice
[45]. The extent of autoimmune disease in Aire KO mice is
dependent on the genetic background [46], with very mild disease
observed on the mixed 129xB6 background [47] (which
Figure 5. TEC population structure is intact in Adam17/Foxn1 mice. (A) Representative staining of gated CD45
-Ter119
- thymic stromal cell
populations from 8-week old Control and Adam17/Foxn1 mice (B and C) Within the EpCAM
+ TEC population, staining for UEA1 alone (B), and MHCII
plus UEA1 (C) are shown, with frequencies of UEA1
-, UEA1
+, UEA1
+MHCII
hi, and UEA1
+MHCII
int indicated. Data are representative of Control, n=6 and
Adam17/Foxn1, n=10. (D) TEC frequencies and (E) total numbers determined based on population frequencies and total cell counts as determined by
FACS. (F) Frequency of the UEA1
+ fraction within the CD45
-Ter119
-EpCAM
+ fraction. (G) Frequencies of MTS15
+ fibroblasts. In Parts D through G, the
graphs report the mean value and each data point represents an individual mouse. Data between genotypes were not statistically significant, with
p.0.05. Control: fl/+ or fl/fl; Adam17/Foxn1: Cre fl/fl.
doi:10.1371/journal.pone.0013528.g005
TEC-Specific ADAM17 Knockout
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used in our studies). Therefore, the unaltered thymus development
observed in Adam17/Foxn1 mice, despite the reduced Aire mRNA
expression in these mice, is of similar phenotype to Aire KO mice.
Little is known about the factors that regulate Aire expression. Aire
expression is highly specific to mature medullary TECs only at
their latest stages of differentiation [33]. Lymphotoxin b receptor
signaling was initially thought to regulate the expression of Aire
[48], but the current consensus now favors the conclusion that
lymphotoxin b receptor signals are required for TEC differenti-
ation but do not impact Aire expression directly [29,49]. We are
convinced that our PCR primers should detect all known Aire
splice variants [50], strongly supporting the idea that Adam17
promotes the transcription of the Aire gene. Aire protein expression
was measured both by flow cytometry and immunohistochemistry,
using different antibodies but with similar results, demonstrating
that the Aire protein levels are close to normal in Adam17/Foxn1
mice. Therefore, one explanation is that low level of Aire mRNA
transcript is sufficient to produce normal Aire protein levels in
Adam17/Foxn1 mice. Alternatively, Adam17 may also play a role in
the turnover of Aire protein. If ADAM17 degrades Aire protein as
part of its normal function, then we might indeed expect to see the
levels of Aire protein to be normal in Adam17/Foxn1 mice even if
Aire mRNA levels are low, due to an increased lifespan of the Aire
protein in the absence of Adam17. The role of ADAM17 as
sheddase and an activator of regulated intramembrane proteolysis
is well documented [5,7,8,9], but to date, the substrates of
ADAM17 have been restricted to extracellular transmembrane
receptor and ligands. In contrast, no direct link between ADAM17
and the regulated turnover of intracellular nuclear proteins, such
as Aire, has been reported. Therefore, further experimentation is
required to confirm whether or not ADAM17 can facilitate Aire
protein turnover in mTECs.
ADAM17 has recently been shown to cleave the RANK
receptor in macrophages [51]. RANK signaling is a key signaling
pathway in the development of mature medullary Aire-expressing
Figure 6. ADAM17 and EGF pathway members are expressed
on non-TEC thymic stromal cells. Enzymatically digested thymi
from B6 mice were FACS-sorted based on TEC and fibroblast markers.
(A) Adam17 expression on CD45
-Ter119
-EpCAM
+ TEC and CD45
-Ter119
--
EpCAM
- non-TEC stroma with Gapdh serving as the internal control. (B)
EGF pathway gene expression levels on the indicated populations
were calculated relative to levels on TECs with Gapdh serving as the
internal control. Data are from 2 independent experiments with each
experiment consisting of n$3 pooled mice. Data report mean + SD. In
these experiments, the cell types were identified as follows: TEC:
CD45
-Ter119
-EpCAM
+MTS15
-; Fibroblast: CD45
-Ter119
-EpCAM
-MTS15
+;
Non TEC/Fibroblast: CD45
-Ter119
-EpCAM
-MTS15
-. TECs were sorted to
an average of 92% purity, fibroblasts to 68.73% purity, and non-TEC/
fibroblast to 95.84% purity. Despite lower fibroblast purity, notably, no
sorted fibroblasts were detected within the TEC gate upon re-analysis
(data not shown).
doi:10.1371/journal.pone.0013528.g006
Figure 7. A revised model of ADAM17’s role in the thymus.
ADAM17 may act in several related manners which collectively regulate
T cell development: 1) ADAM17 may modulate systemic factors in that
can affect T cell development in an endocrine fashion, potentially
through control of DP cell survival; 2) ADAM17 may release factors from
non-TEC stromal cells (such as fibroblasts) that in turn act directly on
thymocytes or on TECs to promote proper T cell development; 3)
ADAM17 in TECs regulates expression of Aire mRNA levels through an
unknown substrate interaction.
doi:10.1371/journal.pone.0013528.g007
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for the induction of Aire expression and mTEC development in
fetal thymic organ cultures, the dependence of RANKL on mTEC
after the embryonic stage is not as severe [52]. Our data show that
adult mTEC frequencies are not affected, and Aire
+ TECs appear
to be mature in the absence of Adam17. Furthermore, although Aire
mRNA levels are severely reduced in adult Adam17/Foxn1 mice,
Aire protein levels are not (Figure 4). Therefore, despite the link
between ADAM17 and RANK signaling, our observation that
TEC populations are normal in Adam17/Foxn1 mice does not
support the hypothesis that ADAM17 is necessary to facilitate
RANK signaling in the adult thymus.
In conclusion, our findings reveal that ADAM17 is dispensable
in TECs for the ability to support T cells to progress through the
characterized stagesof ab T celldevelopment.This contrastswith
conventional Adam17
DZn/DZn mice and suggests a novel role for
ADAM17 in non-TEC stroma or extrathymically-derived
ADAM17 substrates on T cell development. Adam17 has been
deleted under the control of other promoters including Sox9,
resulting in an osteoporotic phenotype due to G-CSF dysregu-
lation [55] and Tie2, revealing a role for Adam17 in pathological
neovascularization [56]. New conditional knockout strategies are
necessary to identify the cell type in which ADAM17 non-
autonomously regulates T cell development. In addition, our
findings indicate that ADAM17 in TECs regulates the expression
of the transcription factor Aire. Further experiments will be
required to identify the exact ADAM17 substrates involved in Aire
regulation and whether and the ADAM17 deficit in TECs leads
to breaches in the regulation of negative selection in thymocytes
and self-tolerance.
Materials and Methods
Ethics Statement
All animal procedures were approved by the UC Merced
Institutional Animal Care and Use Committee (Protocol # UCM
185).
Mice
Adam17
flox/flox mice [23] and Foxn1-Cre mice [27] have been
previously described. Adam17
flox/flox mice were crossed with Foxn1-
Cre mice to generate Foxn1-Cre/Adam17
flox/+ mice, which were
backcrossed with Adam17
flox/flox mice to generate Foxn1-Cre/
Adam17
flox/flox conditional knockouts (referred to as Adam17/Foxn1).
Adam17/Foxn1 mice and littermate controls were of a mixed 129Sv
and C57BL/6 (B6) background. Genotyping for Cre recombinase
was performed using the following primers: forward 59-CGATG-
CAACGAGTGATGAGG-39 and reverse 59-GCATTGCTGT-
CACTTGGTC-39. Cre-expressing mice were distinguished by the
presence of a 288bp amplicon from ear punch DNA samples.
Genotyping for Adam17 was performed using the following
primers: forward 59-GCCACGATTCAGAGTGATTCC-39 and
reverse 59-CTCCATCAGCAGTTAAGAGCAC-39 which al-
lowed clear distinction between the Adam17
+ and Adam17
flox
alleles. B6 mice were purchased from Jackson Laboratories. In our
experiments, control mice were of either the genotype Adam17
flox/+
or Adam17
flox/flox (without Foxn1-Cre). We have confirmed that no
differences in thymocyte and TEC lineages exist between Foxn-1-
Cre/Adam17
+/+ and control mice (data not shown). Mice were
housed pathogen free in sterile microisolator cages under 12 hour
light/dark cycles with ad libitum access to sterile feed and
autoclaved water. Mice were euthanized by CO2 asphyxiation
followed by cervical dislocation.
Thymocyte and TEC isolation
Thymi were harvested and placed in Medium 199 (M199)
(Invitrogen) containing 2% heat inactivated fetal calf serum (FCS)
(Atlanta Biologicals). For thymocyte analysis, thymocytes were
extracted by mechanical disruption with the base of a 5 ml syringe
followed by filtration through 70 mm nylon mesh. For TEC analysis
by flow cytometry [57], thymi were trimmed of excess fat and
connective tissue. Thymi were placed in M199 and the capsule was
nicked in several places with fine scissors. Thymi were agitated with
amagneticstirrerat4uCfor20minutestoremovealargefractionof
thymocytes. Thymic fragments were then transferred into an
enzymatic digestion buffer containing 0.125% (w/v) Collagenase D
(Roche) with 0.1% (v/v) DNAse I (Roche) and gently rotated on an
orbital shaker at 37uC for 15 minutes. Thymic fragments were
pelleted by centrifugation at 3006g and the digestion buffer was
exchanged. After 4 digestions, 0.125% (w/v) dispase (Worthington
Biochemical) was added to the digestion buffer and thymi were
incubated for an additional 15 minutes. After the final digestion,
cells were incubated in PBS containing 5 mM EDTA + 1% FCS
+ 0.02% (w/v) NaN3 for 10 minutes on ice. Cells were passed
several times through a 21G needle and filtered through a 70 mm
nylon mesh. Red blood cells were lysed with ACK lysis buffer
(0.15 M NH4Cl + 10 mM KHCO3 + 0.1 mM Na2EDTA, pH 7.2).
Cells were counted by hemocytometer and population numbers
determined by calculating based on flow cytometric gating.
Antibodies, Flow Cytometry, and Cell Sorting
The anti-EpCAM (clone G8.8, Developmental Studies Hybrid-
oma Bank, University of Iowa) hybridoma was cultured in DMEM
media containing 10% FCS until confluent. Hybridoma superna-
tants were collected and antibodies purified using goat anti-rat
CNBrSepharoseBeads(JacksonImmunohistochemical,Amersham
Biosciences). EpCAM (rat IgG2a) antibody was conjugated to
phycoerythrin using the Lightning Link PE kit (Novus Biological).
The following primary antibodies were purchased from Biolegend:
anti-MHCII-PE/Cy5 (clone MM5/114.15.2), anti-CD80-FITC
(clone 16-10A1), anti-CD45-APC/Cy7 (clone 104), anti-CD4-PE/
Cy7 (clone RM4-5), anti-CD8a-FITC (clone 53–6.7), anti-CD44-
PE (clone IM7), anti-CD25-APC (clone PC61), anti-TCRcd-FITC
(clone UC7-13D5), anti-TCRb-PE (clone H57-597), anti-CD3-
APC (clone 145–2C11), anti-CD19-PE/Cy7 (clone 6D5), anti-
Ter119 (clone Ter-119). The anti-FoxP3-PE antibody (clone FJK-
16s) was purchased from eBioscience. Purified MTS-15 antibody
was a gift of Dr. Richard Boyd, Monash University, Clayton,
Victoria, Australia. Purified anti-Aire antibody (clone 5H12-2 ) was
a gift of Dr. Daniel Gray, Walter and Eliza Hall Institute,
Melbourne, Australia. Rat IgG2c isotype control (clone RTK
4174) was purchased from Biolegend. The lectin Ulex agglutitin-1
(UEA1)-FITC was purchased from Vector Laboratories. The
secondary antibody anti-rat IgG2c-biotin (clone MRG2c-67,
Biolegend) was used to label MTS-15 or anti-Aire, followed by
staining with Streptavidin-FITC (eBioscience) or Streptavidin-PE/
Cy5 (Biolegend). For TEC analysis and sorting, CD45
+ cells were
first depleted by magnetic activated cell sorting (MACS). Cells were
stained with anti-CD45 coated microbeads (Miltenyi Biotech) and
magnetically sorted using the ‘‘DepleteS’’ program on an
AutoMACS cell sorter (Miltenyi Biotech). Prior to antigen staining,
Fc receptors were blocked with anti-CD16/32 (eBioscience). Each
stain was performed on ice for 15 minutes in FACS staining buffer
containing 1x HBSS, 4.2 mM sodium bicarbonate, 0.1% w/v
sodium azide and 1% bovine serum albumin, Fraction V, pH 7.2.
For thymic stromal analysis, the MTS-15 stain was performed first,
then washed and stained with fluorochrome-conjugated primary
antibodies and streptavidin-FITC or PE/Cy5. Labeled cells were
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assess viability of unfixed cells. For Aire and FoxP3 intracellular
stain, surface staining was performed first, followed by fixation and
permeabilization utilizing the buffers in the Foxp3 Staining Set
(eBioscience) accordingtothe manufacturer’sinstructions.ForTEC
isolation, flow cytometric analysis and sorting of the CD45
- fraction
wasperformed ona FACSAriacytometer (BD Biosciences).Thymic
populations were sorted to greater than 95% purity, unless noted
otherwise. Flow cytometric data analysis was performed using
FlowJo software (TreeStar).
RT-PCR and qRT-PCR
Total RNA was extracted from FACS or MACS sorted cells
using the RNeasy kit (Qiagen) and cDNA was generated using the
Superscript III RT kit (Invitrogen) according to the manufacturers’
instructions. Reverse transcriptase PCR (RT-PCR) primers to
Adam17 were designed to span the floxed exon2 with the forward
primer 59-CGGAGGAAGCAGGCTCTG-39 annealing to exon1
and the reverse primer 59-GAGTCAGGCTCACCAACCAC-39
annealing to exon3. This allows discrimination of a wildtype
transcript and a mutant, null transcript resulting from recombi-
nation. After one minute dissociation at 95uC, Adam17 was
amplified from the cDNA over 40 cycles at 95uC for 30 seconds,
57uC for 30 seconds, and 72uC for 1 minute. Quantitative RT-
PCR (qRT-PCR) was performed using SYBR Green PCR master
mix (Applied Biosystems) and samples run on an Applied
Biosystems 7300 Real-Time system. Samples were denatured at
95uC for 2 minutes followed by 40 cycles of 95uC for 15 seconds
and 60uC for 1 minute. The DDCt method was utilized to
determine relative expression levels of the gene of interest between
samples using ribosomal protein L7 (RPL7) as the internal control.
For Adam17 qRT-PCR the above noted forward primer was used
in conjunction with the reverse primer 59-GTTTCTAAGT-
GTGTCGCAGACTG-39 that anneals to exon2. Therefore,
amplification only occurs off the wildtype transcript. The following
other primer sequences were used (forward then reverse): Rpl7,5 9-
GAAGCTCATCTATGAGAAGGC-39 and 59-AAGACGAAG-
GAGCTGCAGAAC-39 [58]; Adam10,5 9- CACTGCCGGGGA-
GGCTCGTCG-39 and 59- CCGCCTCCTCACGGGTTAAC-
CG-39; Aire,5 9-GTACAGCCGCCTGCATAGC-39 and 59-CC-
CTTTCCGGGACTGGTTTA-39; Caseina,5 9-CCTATGAGTG-
TAGTGGATCAGGCA-39 and 59-AGGCATCATACTGGAA-
GATTTGTG-39; Caseinb,5 9-TGTGCTCCAGGCTAAAGTTC-
ACT-39 and 59-GGTTTGAGCCTGAGCATATGG-39; Caseinc,
59-ATGTTGCACACCTCTTCACCAG-39 and 59-GGCGT-
GTTATGGATGGCATT-39; Caseink,5 9-GCCGTGGTGAGA-
AGAATGACA-39 and 59-AAGTTCAGGACGGAGCGGA-39;
Insulin2,5 9-GGGAGTCCCACCCCACCCAG-39 and 59-CAC-
GCTCCCCACACACCAGG-39; Gad67,5 9-GGTTCGCACA-
GGTCACCC-39 and 59-GCCATTCACCAGCTAAACCAA-39;
Spt1,5 9-CTGGTGAAAATACTGGCTCTGAA-39 and 59-AG-
CAGTGTTGGTATCATCAGTG-39. Unless noted otherwise,
primer sequences were obtained from Primerbank (http://pga.
mgh.harvard.edu/primerbank/) or from previous literature [30].
All qRT-PCR primers were validated to be between 90–110%
efficient by a template serial dilution standard curve and to have a
single peak when a dissociation curve was performed.
Immunohistochemistry
Thymi were extracted and snap frozen in OCT compound
(Sakura Finetek) over dry ice. Sectioning of the thymus, tissue
processing protocols, keratin-5, keratin-8 and Aire staining and
morphometry data analysis were performed as described [59].
Statistical Analysis
Differences between means were tested using two-tailed T-test
(GraphPad Prism) and were considered significant if p,0.05 (*),
p,0.01 (**), p,0.001 (***).
Supporting Information
Figure S1 Thymic and splenic regulatory T cells are present in Adam17/
Foxn1 mice. Thymus and spleen from 11-12 week old mice were
harvested. FoxP3 intracellular stain was performed and the
FoxP3+ fraction was determined within the CD4SP thymic
population (A, left and middle panels). CD25 stain was performed
to assess co-localization with FoxP3 stain on CD4SP thymocytes
(A, right panels). Splenic CD4SP lymphocytes assessed for FoxP3
expression (B). Frequency of FoxP3+ thymocytes within the
CD4SP gate (C). All flow plots are representative of indicated
groups. Data represent mean + SD; CD4SP, CD4 single positive;
Control, n=5; Adam17/Foxn1, n=3. Control: fl/+ or fl/fl;
Adam17/Foxn1: Cre fl/fl.
Found at: doi:10.1371/journal.pone.0013528.s001 (3.66 MB TIF)
Figure S2 Adam10 levels are unaltered on ADAM17/Foxn1 TECs and
non-TEC stroma. FACS-sorted CD45-Ter119-EpCAM+ TECs and
CD45-Ter119-EpCAM- stroma were pooled from 8-week old
Control and Adam17/Foxn1 mice (n$3 for each pool). Adam10 levels
were determined in TECs (A) and non-TEC stroma (B). Rpl7 was
used as the internal control and expression levels were determined
relative to mean expression in Control mice. Data represent mean +
SD of 2 independent experiments. No statistically significant
differences were found. Control: fl/+ or fl/fl; Adam17/Foxn1: Cre fl/fl.
Found at: doi:10.1371/journal.pone.0013528.s002 (0.08 MB TIF)
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